Litigation Details for ABBVIE INC. v. SANDOZ INC. (D.N.J. 2018)

ABBVIE INC. v. SANDOZ INC. (D.N.J. 2018)

Docket		Date Filed	2018-08-10
Court	District Court, D. New Jersey	Date Terminated	2018-10-16
Cause	35:271 Patent Infringement	Assigned To	Freda L. Wolfson
Jury Demand	None	Referred To	Lois H. Goodman
Parties	ABBVIE BIOTECHNOLOGY LTD; SANDOZ INTERNATIONAL GMBH
Patents	8,231,876; 8,663,945; 8,715,664; 8,808,700; 8,883,156; 8,889,136; 8,895,009; 8,906,372; 8,906,373; 8,906,646; 8,911,964; 8,916,153; 8,926,975; 8,961,973; 8,961,974; 8,986,693; 8,999,337; 9,018,361; 9,061,005; 9,067,992; 9,073,988; 9,085,618; 9,085,620; 9,090,689; 9,090,867; 9,096,666; 9,102,723; 9,150,645; 9,187,559; 9,193,787; 9,200,069; 9,200,070; 9,234,032; 9,255,143; 9,266,949; 9,273,132; 9,284,370; 9,284,371; 9,290,568; 9,315,574; 9,334,319; 9,346,879; 9,359,434; 9,365,645; 9,505,833; 9,505,834; 9,512,216; 9,522,953; 9,550,826; 9,624,295; 9,669,093; 9,683,033; 9,913,902; 9,957,318
Attorneys	JOHN EDMUND FLAHERTY; RAVIN R. PATEL
Firms	McCarter and English, LLP
Link to Docket	External link to docket

Biologic Drugs cited in ABBVIE INC. v. SANDOZ INC.

Details for ABBVIE INC. v. SANDOZ INC. (D.N.J. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-08-10	1	Complaint	Title Patent No. 3. 8,231,876 Purified Antibody Composition…following two patents in the present lawsuit: U.S. Patent No. 9,187,559 and U.S. Patent No. 9,750,808 … U.S. Patent No. 9,187,559 89. U.S. Patent No. 9,187,559 (the “’559 patent”), titled … U.S. Patent No. 9,750,808 91. U.S. Patent No. 9,750,808 (the “’808 patent”), titled …States Patent and Trademark (“USPTO”) has recognized AbbVie’s innovation, awarding over 100 patents relating	External link to document